For one global biotechnology company, unifying the digital and physical aspects of its supply chain would prove essential in bridging the data gap and optimising operations for its phase I oncology study.

Traditionally, sponsors outsource the digital (IRT) and physical (clinical supplies) aspects of the clinical supply chain to multiple vendors. While this may sometimes offer initial cost benefits, it often represents a false economy. This is because vital information can fall through the gaps between where one vendor’s responsibility ends and another’s begins.

Download our case study to discover how one biotechnology benefited from immediate alignment of its physical and digital operations by using Almac ONE™; a unified supply chain solution.